Knight Therapeutics | GUD - 贸易债权人

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 938.86M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	贸易债权人	更改		日
Acasti Pharma	USD 459K		881K	2025-09
Akebia Therapeutics	USD 8.39M		12.8M	2026-03
Alaunos Therapeutics	USD 400K		213K	2026-03
Aurora Cannabis	CAD 68.03M		18.68M	2025-12
Avita Medical	AUD 8.96M		1.69M	2025-12
Canopy Growth	CAD 19.96M		1.83M	2025-12
Cronos Group	USD 10.28M		1.36M	2026-03
Dianthus Therapeutics	USD 5.27M		4.45M	2026-03
Ionis Pharmaceuticals	USD 26.03M		2.05M	2026-03
IQVIA Holdings	USD 3.64B		112M	2026-03
Knight Therapeutics	CAD 125.76M		7.63M	2025-12
Moderna	USD 161M		156M	2026-03
Omeros	USD 8.84M		4.42M	2025-06
Organigram Holdings	CAD 71.08M		18.17M	2025-12
Organon & Co	USD 983M		31M	2026-03
Revvity	USD 169.68M		15.78M	2026-03
Tectonic Therapeutic	USD 2.55M		1.46M	2026-03
Tilray	USD 114.5M		3.69M	2025-09
Viatris	USD 1.2B		93.9M	2026-03
Xeris Pharmaceuticals	USD 11.47M		8.39M	2026-03